| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |